US Stock MarketDetailed Quotes
EVAX Evaxion Biotech
- 0.920
- +0.030+3.36%
Close Dec 20 16:00 ET
- 0.897
- -0.023-2.53%
Post 20:01 ET
5.40MMarket Cap-0.33P/E (TTM)
0.960High0.884Low73.49KVolume0.890Open0.890Pre Close66.51KTurnover2.00%Turnover RatioLossP/E (Static)5.87MShares13.61052wk High70.77P/B3.38MFloat Cap0.84752wk Low--Dividend TTM3.67MShs Float250.400Historical High--Div YieldTTM8.58%Amplitude0.846Historical Low0.905Avg Price1Lot Size
Evaxion Biotech Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.02M | 154K | 51K | 73K | 73K | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --3.02M | --154K | --51K | --73K | --73K | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -17.60%4.75M | -16.59%4.74M | -29.46%4.45M | -11.85%22.27M | -32.00%4.44M | -5.28%5.76M | -9.30%5.68M | -1.48%6.3M | -2.21%25.26M | -15.49%6.53M |
| Selling and administrative expenses | -27.22%2.13M | -27.65%1.98M | -34.30%1.61M | 24.99%10.08M | -19.24%1.86M | 45.51%2.93M | 27.67%2.74M | 53.73%2.45M | 30.49%8.06M | 54.28%2.31M |
| -General and administrative expense | -27.22%2.13M | -27.65%1.98M | -34.30%1.61M | 24.99%10.08M | -19.24%1.86M | 45.51%2.93M | 27.67%2.74M | 53.73%2.45M | 30.49%8.06M | 54.28%2.31M |
| Research and development costs | -7.63%2.61M | -6.27%2.75M | -26.38%2.84M | -30.14%11.92M | -43.58%2.3M | -30.43%2.83M | -28.60%2.94M | -19.82%3.85M | -12.90%17.06M | -33.82%4.07M |
| Depreciation amortization depletion | ---- | ---- | ---- | 90.97%275K | ---- | ---- | ---- | ---- | 102.82%144K | ---- |
| -Depreciation and amortization | ---- | ---- | ---- | 90.97%275K | ---- | ---- | ---- | ---- | 102.82%144K | ---- |
| Operating profit | 69.96%-1.73M | 19.31%-4.58M | 30.27%-4.4M | 12.14%-22.2M | 33.12%-4.36M | 5.28%-5.76M | 9.30%-5.68M | 1.48%-6.3M | 2.21%-25.26M | 15.49%-6.53M |
| Net non-operating interest income expense | -172.73%-300K | -5.75%-184K | 13,202.44%5.37M | 5.35%-743K | 86.26%-361K | -165.48%-110K | -113.24%-174K | -111.36%-41K | -393.71%-785K | -331.53%-2.63M |
| Non-operating interest income | 16.67%84K | -12.77%41K | 1,871.23%5.62M | 1,084.62%154K | 90.90%-250K | -89.76%72K | -96.95%47K | -45.09%285K | --13K | -112.53%-2.75M |
| Non-operating interest expense | 110.99%384K | 1.81%225K | -24.54%246K | 12.41%897K | 192.50%111K | -65.98%182K | -1.78%221K | 106.33%326K | 401.89%798K | 82.46%-120K |
| Other net income (expense) | -2,763.16%-1.63M | -98.81%25K | -57K | 64.30%2.11M | ||||||
| Gain on sale of security | ---- | -2,763.16%-1.63M | ---- | -98.81%25K | ---- | ---- | ---57K | ---- | 64.30%2.11M | ---- |
| Income before tax | 65.41%-2.03M | -8.28%-6.4M | 115.17%976K | 4.29%-22.92M | 33.29%-4.7M | 0.73%-5.87M | -19.47%-5.91M | -6.58%-6.44M | 3.11%-23.94M | 0.03%-7.05M |
| Income tax | 50.52%-96K | 11.56%-199K | -12.37%-218K | -2.33%-790K | -2.31%-177K | -10.86%-194K | -27.12%-225K | 21.46%-194K | -333.71%-772K | -113.08%-173K |
| Net income | 65.92%-1.94M | -9.06%-6.2M | 119.13%1.19M | 4.51%-22.13M | 34.18%-4.52M | 1.08%-5.68M | -19.19%-5.68M | -7.77%-6.24M | 5.56%-23.17M | 17.90%-6.87M |
| Net income continuous Operations | 65.92%-1.94M | -9.06%-6.2M | 119.13%1.19M | 4.51%-22.13M | 34.18%-4.52M | 1.08%-5.68M | -19.19%-5.68M | -7.77%-6.24M | 5.56%-23.17M | 17.90%-6.87M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 65.92%-1.94M | -9.06%-6.2M | 119.13%1.19M | 4.51%-22.13M | 34.18%-4.52M | 1.08%-5.68M | -19.19%-5.68M | -7.77%-6.24M | 5.56%-23.17M | 17.90%-6.87M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 65.92%-1.94M | -9.06%-6.2M | 119.13%1.19M | 4.51%-22.13M | 34.18%-4.52M | 1.08%-5.68M | -19.19%-5.68M | -7.77%-6.24M | 5.56%-23.17M | 17.90%-6.87M |
| Basic earnings per share | 80.95%-0.4 | 42.86%-1.2 | 112.50%0.3 | 17.35%-8.1 | 48.28%-1.5 | 12.50%-2.1 | -5.00%-2.1 | 4.00%-2.4 | 22.22%-9.8 | 25.64%-2.9 |
| Diluted earnings per share | 80.95%-0.4 | 42.86%-1.2 | 112.50%0.3 | 17.35%-8.1 | 48.28%-1.5 | 12.50%-2.1 | -5.00%-2.1 | 4.00%-2.4 | 22.22%-9.8 | 25.64%-2.9 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data